术后复发的ROS1-重组肺腺癌:一个案例系列
Ryo Miyata1, Ryota Sumitomo2, Ryo Nakanobo3
1Department of Thoracic and Cardiovascular Surgery, Nara Medical University, Nara, Japan.
The Thoracic and cardiovascular surgeon
|December 12, 2025
概括
术后复发的ROS1重组肺癌是不常见的. 克里佐替尼在治疗复发方面表现出有限的疗效,这表明需要进行进一步的临床试验.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 经手术后复发的ROS1重组非小细胞肺癌 (NSCLC) 很少被记录.
- 氨酸激酶抑制剂 (TKIs) 治疗这种复发的疗效尚未得到充分证实.
研究的目的:
- 为了研究完整切除后ROS1重组肺腺癌患者的临床过程和结果.
- 评估TKIs,特别是crizotinib在治疗术后复发中的作用和有效性.
主要方法:
- 对四名完全切除ROS1阳性肺腺癌患者的回顾性审查,这些患者经历了复发.
- 分析无病间隔,整体存活率,复发模式和TKI治疗结果.
主要成果:
- 中位数无疾病间隔为33.4个月.
- 大脑转移是最初复发的最常见地点 (75%).
- 克里佐替尼的疗效有限,中位数无进展生存期为3.5个月.
结论:
- 经ROS1重组的NSCLC可能在切除后表现出惰的行为.
- 目前的技术知识,包括crizotinib,为管理术后复发提供有限的益处.
- 辅助性临床试验是有必要的,以探索更有效的治疗策略.
相关概念视频
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...